J&J loses key tuberculosis drug patent in India

J&J loses key tuberculosis drug patent in India

India’s Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson’s application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions. India accounted for nearly 29 percent of 10.6 million tuberculosis…

Read More